8-K
filed November 7, 2024, 6:59 PM ET
ticker OSCR
CIK 0001568651
earnings
confidence high
sentiment positive
materiality 0.75
Oscar Health Q3 revenue $2.4B (+68% YoY); narrows loss; raises FY revenue guidance
Oscar Health, Inc.
2024-Q3 EPS reported
$0.65
revenue$6,785,128,000
- Total revenue $2.4B, +68% YoY; net loss $54.6M ($0.22 EPS) improved $10.8M YoY.
- Membership grew to 1.65M from 983k YoY, driven by Individual and Small Group (1.60M).
- Adjusted EBITDA loss $11.6M, improved $8.7M YoY; SG&A expense ratio improved to 19.0% from 22.6%.
- FY2024 revenue guidance raised to $9.2-9.3B; expects net income profitability this year.
- Medical Loss Ratio 84.6%, up 80bps YoY due to higher medical costs and risk adjustment.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001568651-24-000029
- form_type
- 8-K
- ticker
- OSCR
- cik
- 0001568651
- company_name
- Oscar Health, Inc.
- filed_at
- 2024-11-07T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:08.826612+00:00
- generated_at
- 2026-05-30T03:33:16.519275+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001568651-24-000029
- json_url
- https://secwatch.observer/filing/0001568651-24-000029.json
- markdown_url
- https://secwatch.observer/filing/0001568651-24-000029.md
- text_url
- https://secwatch.observer/filing/0001568651-24-000029.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1568651/000156865124000029/0001568651-24-000029-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1568651/000156865124000029/oscr-20241107.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
YSWY
Yesway reports Q1 net income $30.2M, Adjusted EBITDA $59.2M; introduces FY2026 outlook
Yesway, Inc.
June 2, 2026, 7:35 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
VSCO
Victoria's Secret Q1 sales up 15% to $1.56B, beats guidance; raises FY2026 outlook
Victoria's Secret & Co.
June 2, 2026, 7:01 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SIG
Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance
SIGNET JEWELERS LTD
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DG
Dollar General Q1 EPS $2.00 beats expectations; raises FY2026 EPS guidance
DOLLAR GENERAL CORP
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 5.07, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HIVE
HIVE FY2026 revenue $297.8M (+158% YoY); GAAP net loss $148.4M
HIVE Digital Technologies Ltd.
June 2, 2026, 6:23 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DCI
Donaldson Q3 FY2026 sales $995.1M (+5.8%), adj. EPS $1.06 (+7.1%)
DONALDSON Co INC
June 1, 2026, 5:41 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.